Worth reading
40Recurring
Scored from 3 of 5 sectionsDirection
Neutral
Direction inferred from the company’s description.Scale
68000
SharesWording
Definitive
How definitive the wording is.Details of issuance or disposal
Series 19 Stock Acquisition Rights (Tax-Qualified Stock Options), Series 20 Stock Acquisition Rights (Paid Stock Options)
Who receives how much
Type Common shares / Number of Shares 18,900 shares (Series 19), Type Common shares / Number of Shares 49,100 shares (Series 20)
The Company’s directors and 10 employees189 stock acquisition rights
The Company’s directors and 15 employees491 stock acquisition rights
The height of each bar represents the proportion of shares received by each allottee. The thin line below represents the number of existing shares to which these shares are added.
Terms of the stock acquisition rights
Exercise price
Category Series 19 / Initial exercise price ¥1,815 per share (¥181,500 per stock acquisition right) / Revision Clause Not disclosed / Lower Limit of Revision Not disclosed, Category Series 20 / Initial exercise price ¥1,650 per share (¥165,000 per stock acquisition right) / Revision Clause Not disclosed / Lower Limit of Revision Not disclosed
Number of Stock Acquisition Rights
Total number issued Series 19: 189 rights; Series 20: 491 rights / Number of unexercised units Not disclosed
Categories and Number of Persons Covered
Category The Company's directors and employees / Number of Employees 10 / Number of allocated shares 18,900 shares (189 rights), Category The Company's directors and employees / Number of Employees 15 / Number of allocated shares 49,100 shares (491 rights)
| Item | Details |
|---|---|
| Type of issuance or disposal | Series 19 Stock Acquisition Rights (Tax-Qualified Stock Options), Series 20 Stock Acquisition Rights (Paid Stock Options) |
| Number of shares to be issued or disposed of | Type Common shares / Number of Shares 18,900 shares (Series 19), Type Common shares / Number of Shares 49,100 shares (Series 20) |
| Intended allottee | Category The Company’s directors and 10 employees / Number of units 189 stock acquisition rights, Category The Company’s directors and 15 employees / Number of units 491 stock acquisition rights |
| Exercise price | Category Series 19 / Initial exercise price ¥1,815 per share (¥181,500 per stock acquisition right) / Revision Clause Not disclosed / Lower Limit of Revision Not disclosed, Category Series 20 / Initial exercise price ¥1,650 per share (¥165,000 per stock acquisition right) / Revision Clause Not disclosed / Lower Limit of Revision Not disclosed |
| Number of Stock Acquisition Rights | Total number issued Series 19: 189 rights; Series 20: 491 rights / Number of unexercised units Not disclosed |
| Categories and Number of Persons Covered | Category The Company's directors and employees / Number of Employees 10 / Number of allocated shares 18,900 shares (189 rights), Category The Company's directors and employees / Number of Employees 15 / Number of allocated shares 49,100 shares (491 rights) |
Items this document does not state (22)
Issue price and disposal priceTotal issue valueAmount of funds to be raisedEstimated issuance expensesSpecific use of fundsPayment dateIntended allottee's holding policyDilution RateTotal number of issued sharesBasis for determining the amount to be paidExercise periodTransfer restriction periodConditions for lifting transfer restrictionsReason for acquisition without considerationTotal Stock-Based CompensationUnderwriter / lead underwriterOverallotmentStock Split RatioProcedures under the Corporate Code of ConductMost recent equity financingMajor shareholders after the offeringImpact on Business Performance
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.The issuance details for the stock acquisition rights were finalized based on a resolution of the Board of Directors.
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.